← Browse by Condition
Medical Condition

crohn disease

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
NCT06042387
Recruiting

Genome Analysis Across Populations in Inflammatory Bowel Disease

Enrollment
150 pts
Location
Canada
Sponsor
Mount Sinai Hospital, Canada
View Trial →
NCT06631586 Phase 2
Recruiting

Standardized Microbiota Transplant Therapy in Crohn's Disease

Enrollment
120 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT06298188
Recruiting

Risankizumab in Children With Crohn's Disease (RisaKids)

Enrollment
90 pts
Location
Israel
Sponsor
Shaare Zedek Medical Center
View Trial →
NCT06221254
Recruiting

A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease

Enrollment
200 pts
Location
Israel
Sponsor
Soroka University Medical Cent...
View Trial →
NCT05835973
Recruiting

Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.

Enrollment
216 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT04263831 Phase 1, Phase 2
Recruiting

Low Dose IL-2 for the Treatment of Crohn's Disease

Enrollment
30 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT06550310
Recruiting

Nutrition and Clinical Outcomes in IBD

Enrollment
300 pts
Location
United Kingdom
Sponsor
Barts & The London NHS Trust
View Trial →
NCT05230173
Recruiting

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Enrollment
250 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT03816345 Phase 1
Recruiting

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT05903066
Recruiting

TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)

Enrollment
210 pts
Location
Belgium, France
Sponsor
Groupe d'Etude Therapeutique d...
View Trial →
NCT05294107
Recruiting

Intestinal Organoids

Enrollment
90 pts
Location
France
Sponsor
Rennes University Hospital
View Trial →
NCT06051253 Phase 4
Recruiting

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

Enrollment
86 pts
Location
South Korea
Sponsor
Asan Medical Center
View Trial →
NCT04912999
Recruiting

Inflammatory Bowel Diseases Remission Registry

Enrollment
1,000 pts
Location
Israel
Sponsor
Tel-Aviv Sourasky Medical Cent...
View Trial →
NCT04803916
Recruiting

Pre-stenotic Inflammation Following Endoscopic Balloon Dilatation in Crohn's Disease: A Prospective Study

Enrollment
24 pts
Location
Israel
Sponsor
Shaare Zedek Medical Center
View Trial →
NCT06203782
Recruiting

Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures

Enrollment
102 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →